Physician profile
Oscar Lu
NPI 1649775735
$847.04
in general payments reported to CMS, 2019-2025
13 companies · $45.87 in 2025
The $45.87 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $48.84 · 2022: $346 · 2023: $356 · 2024: $50.74 · 2025: $45.87.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $452.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $452.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $402.71 | 2022-2025 | |
| Kowa Pharmaceuticals America, INC. | $95.90 | 2022-2025 | Zoryve, Livalo |
| Idorsia Pharmaceuticals US INC | $86.81 | 2022-2023 | Quviviq |
| Novo Nordisk INC | $54.32 | 2022-2023 | Ozempic, Rybelsus |
| Merck Sharp & Dohme LLC | $48.84 | 2019 | |
| Lilly USA, LLC | $36.94 | 2023-2024 | Mounjaro |
| Janssen Pharmaceuticals, INC | $33.03 | 2023 | Xarelto |
| Otsuka America Pharmaceutical, INC. | $22.29 | 2023 | Rexulti |
| Sanofi-Aventis U.S. LLC | $21.13 | 2023 | |
| Glaxosmithkline, LLC. | $13.62 | 2022 | |
| Radius Health, INC. | $13.30 | 2023 | Tymlos |
| Astrazeneca Pharmaceuticals LP | $12.80 | 2023 | |
| Phathom Pharmaceuticals, INC. | $5.35 | 2025 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Oscar Lu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.